The system works on the direct electrical detection and sequencing of DNA and RNA. By a proprietary fabrication process, nanoscale gaps between sensing electrodes are formed through which strands of DNA and RNA translocate. A bias voltage applied across the gap slows the motion of the molecule and is used to measure its conductance. Investors are Innovation Network Corporation of Japan, Mitsubishi UFJ Capital, JAFCO, UTEC and Mizuho Capital.
Quantum Biosystems news release, Feb. 9, 2015
Quantum Biosystems raises 2,4 billion Yen (~20 million €) for development of its Hinomaru sequencer